Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Follicular 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Colorectal Neoplasms 2 Virus Diseases 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Pregnancy Related 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Glioma 1 Glioblastoma 1 Epstein-Barr Virus Infections 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Breast Neoplasms, Male 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 254 fludarabine phosphate 165 Cytarabine 160 Methotrexate 128 Busulfan 115 Filgrastim 111 fludarabine 102 Peripheral Blood Stem Cell Transplantation 96 Rituximab 94 Antilymphocyte Serum 83 Etoposide 81 Cyclosporine 75 Tacrolimus 74 Mycophenolic Acid 73 Whole-Body Irradiation 72 Radiotherapy 70 Melphalan 66 Vincristine 55 Dexamethasone 54 Granulocyte Colony-Stimulating Factor 50 Methylprednisolone 48 Azacitidine 44 Alemtuzumab 42 Imatinib Mesylate 41 Clofarabine 41 sargramostim 40 Idarubicin 36 Daunorubicin 36 Cord Blood Stem Cell Transplantation 36 Mercaptopurine 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leukemia × Antibodies, Monoclonal × Clear all

NCT00515892 2007-08-14

NHL

Cambridge Antibody Technology

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡